Taylor M. Complementary and alternative approaches to menopause. Endocrinol Metab Clin North Am. 2015;44(3):619–48.
Dietz BM, Hajirahimkhan A, Dunlap TL, Bolton JL. Botanicals and their bioactive phytochemicals for women’s health. Pharmacol Rev. 2016;68(4):1026–73.
Cirillo C, Capasso R. Constipation and botanical medicines: an overview. Phytother Res PTR. 2015;29(10):1488–93.
Neyrinck AM, Etxeberria U, Taminiau B, Daube G, Van Hul M, Everard A, et al. Rhubarb extract prevents hepatic inflammation induced by acute alcohol intake, an effect related to the modulation of the gut microbiota. Mol Nutr Food Res. 2017;61(1):1500899.
Lin TJ, Lin CF, Chiu CH, Lee MC, Horng JT. Inhibition of endosomal fusion activity of influenza virus by Rheum tanguticum (da-huang). Sci Rep. 2016;6:27768.
Yan J, Xie G, Liang C, Hu Y, Zhao A, Huang F, et al. Herbal medicine Yinchenhaotang protects against alpha-naphthylisothiocyanate-induced cholestasis in rats. Sci Rep. 2017;7(1):4211.
Hu X, Liu S, Zhu J, Ni H. Dachengqi decoction alleviates acute lung injury and inhibits inflammatory cytokines production through TLR4/NF-kappaB signaling pathway in vivo and in vitro. J Cell Biochem. 2019;120(6):8956–64.
Gong Z, Lin J, Zheng J, Wei L, Liu L, Peng Y, et al. Dahuang Zhechong pill attenuates CCl4-induced rat liver fibrosis via the PI3K-Akt signaling pathway. J Cell Biochem. 2020;121(2):1431–40.
Huang Q, Lu G, Shen HM, Chung MC, Ong CN. Anti-cancer properties of anthraquinones from rhubarb. Med Res Rev. 2007;27(5):609–30.
Sun J, Wu Y, Dong S, Li X, Gao W. Influence of the drying method on the bioactive compounds and pharmacological activities of rhubarb. J Sci Food Agric. 2018;98(9):3551–62.
Li L, Song X, Yin Z, Jia R, Li Z, Zhou X, et al. The antibacterial activity and action mechanism of emodin from Polygonum cuspidatum against Haemophilus parasuis in vitro. Microbiol Res. 2016;186–187:139–45.
Ahn SM, Kim HN, Kim YR, Choi YW, Kim CM, Shin HK, et al. Emodin from Polygonum multiflorum ameliorates oxidative toxicity in HT22 cells and deficits in photothrombotic ischemia. J Ethnopharmacol. 2016;188:13–20.
Yang J, Zhu A, Xiao S, Zhang T, Wang L, Wang Q, et al. Anthraquinones in the aqueous extract of Cassiae semen cause liver injury in rats through lipid metabolism disorder. Phytomedicine. 2019;64:153059.
Moreira TF, Sorbo JM, Souza FO, Fernandes BC, Ocampos FMM, de Oliveira DMS, et al. Emodin, physcion, and crude extract of Rhamnus sphaerosperma var. pubescens induce mixed cell death, increase in oxidative stress, DNA damage, and inhibition of AKT in cervical and oral squamous carcinoma cell lines. Oxid Med Cell Longev. 2018;2018:2390234.
Dong X, Fu J, Yin X, Cao S, Li X, Lin L, et al. Emodin: a review of its pharmacology, toxicity and pharmacokinetics. Phytotherapy research : PTR. 2016;30(8):1207–18.
Song YD, Li XZ, Wu YX, Shen Y, Liu FF, Gao PP, et al. Emodin alleviates alternatively activated macrophage and asthmatic airway inflammation in a murine asthma model. Acta Pharmacol Sin. 2018;39(8):1317–25.
Ding Y, Xu J, Cheng LB, Huang YQ, Wang YQ, Li H, et al. Effect of emodin on coxsackievirus B3m mediated-encephalitis in hand, foot and mouth disease by inhibiting toll-like receptor 3 pathway in vitro and in vivo. J Infect Dis. 2020;222(3):443–55.
Wu CC, Chen MS, Cheng YJ, Ko YC, Lin SF, Chiu IM, et al. Emodin inhibits EBV reactivation and represses NPC tumorigenesis. Cancers. 2019;11(11):1795.
Chang KC, Li L, Sanborn TM, Shieh B, Lenhart P, Ammar D, et al. Characterization of emodin as a therapeutic agent for diabetic cataract. J Nat Prod. 2016;79(5):1439–44.
Lin L, Liu Y, Fu S, Qu C, Li H, Ni J. Inhibition of mitochondrial complex function-the hepatotoxicity mechanism of emodin based on quantitative proteomic analyses. Cells. 2019;8(3):263.
Wang C, Dai X, Liu H, Yi H, Zhou D, Liu C, et al. Involvement of PPARγ in emodin-induced HK-2 cell apoptosis. Toxicol In Vitro. 2015;29(1):228–33.
Rossi M, Wen K, Caruso F, Belli S. Emodin scavenging of superoxide radical includes π-π Interaction. X-ray crystal structure, hydrodynamic voltammetry and theoretical studies. Antioxidants. 2020;9(3):194.
Hoesel B, Schmid JA. The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.
Xu K, Zhou T, Huang Y, Chi Q, Shi J, Zhu P, et al. Anthraquinone emodin inhibits tumor necrosis factor alpha-induced calcification of human aortic valve interstitial cells via the NF-κB pathway. Front Pharmacol. 2018;9:1328.
Luo S, Deng X, Liu Q, Pan Z, Zhao Z, Zhou L, et al. Emodin ameliorates ulcerative colitis by the flagellin-TLR5 dependent pathway in mice. Int Immunopharmacol. 2018;59:269–75.
Ding Y, Liu P, Chen ZL, Zhang SJ, Wang YQ, Cai X, et al. Emodin attenuates lipopolysaccharide-induced acute liver injury via inhibiting the TLR4 signaling pathway in vitro and in vivo. Front Pharmacol. 2018;9:962.
Zhu T, Zhang W, Feng SJ, Yu HP. Emodin suppresses LPS-induced inflammation in RAW264.7 cells through a PPARgamma-dependent pathway. Int Immunopharmacol. 2016;34:16–24.
Zhang W, Lu X, Wang W, Ding Z, Fu Y, Zhou X, et al. Inhibitory effects of emodin, thymol, and astragalin on leptospira interrogans-induced inflammatory response in the uterine and endometrium epithelial cells of mice. Inflammation. 2017;40(2):666–75.
Ka SO, Hwang HP, Jang JH, Hyuk Bang I, Bae UJ, Yu HC, et al. The protein kinase 2 inhibitor tetrabromobenzotriazole protects against renal ischemia reperfusion injury. Sci Rep. 2015;5:14816.
Marques-Rocha JL, Samblas M, Milagro FI, Bressan J, Martínez JA, Marti A. Noncoding RNAs, cytokines, and inflammation-related diseases. FASEB J. 2015;29(9):3595–611.
Ou C, Li G. Long non-coding RNA TUG1: a novel therapeutic target in small cell lung cancer. J Thorac Dis. 2017;9(7):E644–5.
Katsushima K, Natsume A, Ohka F, Shinjo K, Hatanaka A, Ichimura N, et al. Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat Commun. 2016;7:13616.
Liang Z, Ren C. Emodin attenuates apoptosis and inflammation induced by LPS through up-regulating lncRNA TUG1 in murine chondrogenic ATDC5 cells. Biomed Pharmacother. 2018;103:897–902.
Zang L, Song Y, Yu F, Liu X. Emodin relieved lipopolysaccharide-evoked inflammatory damage in WI-38 cells by up-regulating taurine up-regulated gene 1. BioFactors. 2020;46(5):860–8.
Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27(34):5848–56.
Dong H, Lei J, Ding L, Wen Y, Ju H, Zhang X. MicroRNA: function, detection, and bioanalysis. Chem Rev. 2013;113(8):6207–33.
Shiga A, Nozaki H, Yokoseki A, Nihonmatsu M, Kawata H, Kato T, et al. Cerebral small-vessel disease protein HTRA1 controls the amount of TGF-beta1 via cleavage of proTGF-beta1. Hum Mol Genet. 2011;20(9):1800–10.
Xiang H, Tao X, Xia S, Qu J, Song H, Liu J, et al. Emodin Alleviates sodium taurocholate-induced pancreatic acinar cell injury via microRNA-30a-5p-mediated inhibition of high-temperature requirement A/transforming growth factor beta 1 inflammatory signaling. Front Immunol. 2017;8:1488.
Xie R, Liu M, Li S. Emodin weakens liver inflammatory injury triggered by lipopolysaccharide through elevating microRNA-145 in vitro and in vivo. Artif Cells Nanomed Biotechnol. 2019;47(1):1877–87.
Jeffries J, Zhou W, Hsu AY, Deng Q. miRNA-223 at the crossroads of inflammation and cancer. Cancer Lett. 2019;451:136–41.
Yang Y, Jiang Z, Zhuge D. Emodin attenuates lipopolysaccharide-induced injury via down-regulation of miR-223 in H9c2 cells. Int Heart J. 2019;60(2):436–43.
Song Y, Cui X, Zhao R, Hu L, Li Y, Liu C. Emodin protects against lipopolysaccharide-induced inflammatory injury in HaCaT cells through upregulation of miR-21. Artif Cells Nanomed Biotechnol. 2019;47(1):2654–61.
Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140(6):821–32.
Han JW, Shim DW, Shin WY, Heo KH, Kwak SB, Sim EJ, et al. Anti-inflammatory effect of emodin via attenuation of NLRP3 inflammasome activation. Int J Mol Sci. 2015;16(4):8102–9.
Giuliani AL, Sarti AC, Falzoni S, Di Virgilio F. The P2X7 receptor-interleukin-1 liaison. Front Pharmacol. 2017;8:123.
Zhang Q, Tao X, Xia S, Qu J, Song H, Liu J, et al. Emodin attenuated severe acute pancreatitis via the P2X ligandgated ion channel 7/NODlike receptor protein 3 signaling pathway. Oncol Rep. 2019;41(1):270–8.
Zhang Q, Hu F, Guo F, Zhou Q, Xiang H, Shang D. Emodin attenuates adenosine triphosphate-induced pancreatic ductal cell injury in vitro via the inhibition of the P2X7/NLRP3 signaling pathway. Oncol Rep. 2019;42(4):1589–97.
Gao Z, Sui J, Fan R, Qu W, Dong X, Sun D. Emodin protects against acute pancreatitis-associated lung injury by inhibiting NLPR3 inflammasome activation via Nrf2/HO-1 signaling. Drug Des Dev Ther. 2020;14:1971–82.
Xu Q, Wang M, Guo H, Liu H, Zhang G, Xu C, et al. Emodin alleviates severe acute pancreatitis-associated acute lung injury by inhibiting the cold-inducible RNA-binding protein (CIRP)-mediated activation of the NLRP3/IL-1β/CXCL1 signaling. Front Pharmacol. 2021;12:655372.
Ye B, Chen X, Dai S, Han J, Liang X, Lin S, et al. Emodin alleviates myocardial ischemia/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes. Drug Des Dev Ther. 2019;13:975–90.
Chen YK, Xu YK, Zhang H, Yin JT, Fan X, Liu DD, et al. Emodin alleviates jejunum injury in rats with sepsis by inhibiting inflammation response. Biomed Pharmacother. 2016;84:1001–7.
Medford AR, Millar AB. Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Thorax. 2006;61(7):621–6.
Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004;56(4):549–80.
Li X, Shan C, Wu Z, Yu H, Yang A, Tan B. Emodin alleviated pulmonary inflammation in rats with LPS-induced acute lung injury through inhibiting the mTOR/HIF-1alpha/VEGF signaling pathway. Inflamm Res. 2020;69(4):365–73.
Wamil M, Battle JH, Turban S, Kipari T, Seguret D, de Sousa PR, et al. Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes. 2011;60(4):1158–67.
Esteves CL, Kelly V, Breton A, Taylor AI, West CC, Donadeu FX, et al. Proinflammatory cytokine induction of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) in human adipocytes is mediated by MEK, C/EBPbeta, and NF-kappaB/RelA. J Clin Endocrinol Metab. 2014;99(1):E160-168.
Lai W, Tian X, Xiang Q, Chu K, Wei Y, Deng J, et al. 11beta-HSD1 modulates LPS-induced innate immune responses in adipocytes by altering expression of PTEN. Mol Endocrinol. 2015;29(4):558–70.
Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11(11):723–37.
Iwanowycz S, Wang J, Altomare D, Hui Y, Fan D. Emodin bidirectionally modulates macrophage polarization and epigenetically regulates macrophage memory. J Biol Chem. 2016;291(22):11491–503.
Lloyd CM, Hessel EM. Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol. 2010;10(12):838–48.
Wang T, Zhong XG, Li YH, Jia X, Zhang SJ, Gao YS, et al. Protective effect of emodin against airway inflammation in the ovalbumin-induced mouse model. Chin J Integr Med. 2015;21(6):431–7.
Golubovskaya V, Wu L. Different subsets of T cells, memory, effector functions, and CAR-T immunotherapy. Cancers. 2016;8(3):36.
Sharma R, Tiku AB. Emodin inhibits splenocyte proliferation and inflammation by modulating cytokine responses in a mouse model system. J Immunotoxicol. 2016;13(1):20–6.
Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Rolinski J. Immune disorders in Hashimoto’s thyroiditis: what do we know so far? J Immunol Res. 2015;2015:979167.
Sun H, Ye Z, Li N, Jin F, Yan J, Wu K. Effect of emodin on T cell subsets in NOD mice with NaIinduced experimental autoimmune thyroiditis. Mol Med Rep. 2018;18(5):4303–12.
Qiu F, Liu H, Liang CL, Nie GD, Dai Z. A New Immunosuppressive molecule emodin Induces both CD4(+)FoxP3(+) and CD8(+)CD122(+) regulatory T cells and suppresses murine allograft rejection. Front Immunol. 2017;8:1519.
Shang Y, Smith S, Hu X. Role of Notch signaling in regulating innate immunity and inflammation in health and disease. Protein Cell. 2016;7(3):159–74.
Hua S, Liu F, Wang M. Emodin alleviates the airway inflammation of cough variant asthma in mice by regulating the notch pathway. Med Sci Monit. 2019;25:5621–9.
Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18(2):134–47.
Zhu M, Yuan K, Lu Q, Zhu Q, Zhang S, Li X, et al. Emodin ameliorates rheumatoid arthritis by promoting neutrophil apoptosis and inhibiting neutrophil extracellular trap formation. Mol Immunol. 2019;112:188–97.
Wang GJ, Wang Y, Teng YS, Sun FL, Xiang H, Liu JJ, et al. Protective effects of emodin-induced neutrophil apoptosis via the Ca(2+)-caspase 12 pathway against SIRS in rats with severe acute pancreatitis. Biomed Res Int. 2016;2016:1736024.
Ning JW, Zhang Y, Yu MS, Gu ML, Xu J, Usman A, et al. Emodin alleviates intestinal mucosal injury in rats with severe acute pancreatitis via the caspase-1 inhibition. Hepatobiliary Pancreat Dis Inte. 2017;16(4):431–6.
Rockey DC, Bell PD, Hill JA. Fibrosis–a common pathway to organ injury and failure. N Engl J Med. 2015;372(12):1138–49.
Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325–38.
Liu F, Zhang J, Qian J, Wu G, Ma Z. Emodin alleviates CCl4induced liver fibrosis by suppressing epithelialmesenchymal transition and transforming growth factorbeta1 in rats. Mol Med Rep. 2018;18(3):3262–70.
Zhao XA, Chen G, Liu Y, Wu H, Chen J, Xiong Y, et al. Emodin alleviates liver fibrosis of mice by reducing infiltration of Gr1(hi) monocytes. Evid Based Complement Altern Med. 2018;2018:5738101.
Wang X, Niu C, Zhang X, Dong M. Emodin suppresses activation of hepatic stellate cells through p38 mitogen-activated protein kinase and Smad signaling pathways in vitro. Phytother Res. 2018;32(12):2436–46.
Guan R, Wang X, Zhao X, Song N, Zhu J, Wang J, et al. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation. Sci Rep. 2016;6:35696.
Yang T, Wang J, Pang Y, Dang X, Ren H, Liu Y, et al. Emodin suppresses silica-induced lung fibrosis by promoting Sirt1 signaling via direct contact. Mol Med Rep. 2016;14(5):4643–9.
Gao R, Chen R, Cao Y, Wang Y, Song K, Zhang Y, et al. Emodin suppresses TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial cells through Notch signaling pathway. Toxicol Appl Pharmacol. 2017;318:1–7.
Zhou L, Gao R, Hong H, Li X, Yang J, Shen W, et al. Emodin inhibiting neutrophil elastase-induced epithelial-mesenchymal transition through Notch1 signalling in alveolar epithelial cells. J Cell Mol Med. 2020;24(20):11998–2007.
Ma L, Li H, Zhang S, Xiong X, Chen K, Jiang P, et al. Emodin ameliorates renal fibrosis in rats via TGF-beta1/Smad signaling pathway and function study of Smurf 2. Int Urol Nephrol. 2018;50(2):373–82.
Pechkovsky DV, Prele CM, Wong J, Hogaboam CM, McAnulty RJ, Laurent GJ, et al. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF. Am J Pathol. 2012;180(4):1398–412.
Guan R, Zhao X, Wang X, Song N, Guo Y, Yan X, et al. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats. Toxicol Lett. 2016;262:161–72.
Verfaillie T, Rubio N, Garg AD, Bultynck G, Rizzuto R, Decuypere JP, et al. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death Differ. 2012;19(11):1880–91.
Xiong G, Chen H, Wan Q, Dai J, Sun Y, Wang J, et al. Emodin promotes fibroblast apoptosis and prevents epidural fibrosis through PERK pathway in rats. J Orthop Surg Res. 2019;14(1):319.
Qin W, Du N, Zhang L, Wu X, Hu Y, Li X, et al. Genistein alleviates pressure overload-induced cardiac dysfunction and interstitial fibrosis in mice. Br J Pharmacol. 2015;172(23):5559–72.
Carver W, Fix E, Fix C, Fan D, Chakrabarti M, Azhar M. Effects of emodin, a plant-derived anthraquinone, on TGF-β1-induced cardiac fibroblast activation and function. J Cell Physiol. 2021. https://doi.org/10.1002/jcp.30416.
Xiao D, Zhang Y, Wang R, Fu Y, Zhou T, Diao H, et al. Emodin alleviates cardiac fibrosis by suppressing activation of cardiac fibroblasts via upregulating metastasis associated protein 3. Acta pharmaceutica Sinica B. 2019;9(4):724–33.
Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D’Orazi G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging. 2016;8(4):603–19.
Fang N, Zhang W, Xu S, Lin H, Wang Z, Liu H, et al. TRIB3 alters endoplasmic reticulum stress-induced beta-cell apoptosis via the NF-kappaB pathway. Metab Clin Exp. 2014;63(6):822–30.
Su J, Yan Y, Qu J, Xue X, Liu Z, Cai H. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-kappaB pathway. Oncol Rep. 2017;37(3):1565–72.
Cui Y, Lu P, Song G, Liu Q, Zhu D, Liu X. Involvement of PI3K/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis. Food Chem Toxicol. 2016;92:26–37.
Lin W, Zhong M, Yin H, Chen Y, Cao Q, Wang C, et al. Emodin induces hepatocellular carcinoma cell apoptosis through MAPK and PI3K/AKT signaling pathways in vitro and in vivo. Oncol Rep. 2016;36(2):961–7.
Zhang L, He D, Li K, Liu H, Wang B, Zheng L, et al. Emodin targets mitochondrial cyclophilin D to induce apoptosis in HepG2 cells. Biomed Pharmacother. 2017;90:222–8.
Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat Rev Drug Discovery. 2017;16(4):273–84.
Saunders IT, Mir H, Kapur N, Singh S. Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways. Cancer Cell Int. 2019;19:98.
Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528–42.
Wang Y, Luo Q, He X, Wei H, Wang T, Shao J, et al. Emodin induces apoptosis of colon cancer cells via induction of autophagy in a ROS-dependent manner. Oncol Res. 2018;26(6):889–99.
Trybus W, Krol T, Trybus E, Kopacz-Bednarska A, Krol G, Karpowicz E. Changes in the lysosomal system of cervical cancer cells induced by emodin action. Anticancer Res. 2017;37(11):6087–96.
Zhou J, Li G, Han G, Feng S, Liu Y, Chen J, et al. Emodin induced necroptosis in the glioma cell line U251 via the TNF-α/RIP1/RIP3 pathway. Invest New Drugs. 2020;38(1):50–9.
Janssen A, Medema RH. Mitosis as an anti-cancer target. Oncogene. 2011;30(25):2799–809.
Recasens A, Munoz L. Targeting cancer cell dormancy. Trends Pharmacol Sci. 2019;40(2):128–41.
Wang Y, Yu H, Zhang J, Ge X, Gao J, Zhang Y, et al. Anti-tumor effect of emodin on gynecological cancer cells. Cell Oncol. 2015;38(5):353–63.
Trybus W, Krol T, Trybus E, Stachurska A, Krol G, Kopacz-Bednarska A. Emodin induces death in human cervical cancer cells through mitotic catastrophe. Anticancer Res. 2019;39(2):679–86.
Deng G, Ju X, Meng Q, Yu ZJ, Ma LB. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway. Mol Med Rep. 2015;12(3):4427–33.
Haque E, Kamil M, Irfan S, Sheikh S, Hasan A, Nazir A, et al. Blocking mutation independent p53 aggregation by emodin modulates autophagic cell death pathway in lung cancer. Int J Biochem Cell Biol. 2018;96:90–5.
Chen Y, Mei X, Gan D, Wu Z, Cao Y, Lin M, et al. Integration of bioinformatics and experiments to identify TP53 as a potential target in Emodin inhibiting diffuse large B cell lymphoma. Biomed Pharmacother. 2018;107:226–33.
Navarro F, Lieberman J. miR-34 and p53: new Insights into a complex functional relationship. PloS ONE. 2015;10(7):e0132767.
Bai J, Wu J, Tang R, Sun C, Ji J, Yin Z, et al. Emodin, a natural anthraquinone, suppresses liver cancer in vitro and in vivo by regulating VEGFR(2) and miR-34a. Invest New Drugs. 2020;38(2):229–45.
Dai G, Ding K, Cao Q, Xu T, He F, Liu S, et al. Emodin suppresses growth and invasion of colorectal cancer cells by inhibiting VEGFR2. Eur J Pharmacol. 2019;859:172525.
Masoud GN, Li W. HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta pharmaceutica Sinica B. 2015;5(5):378–89.
Ma F, Hu L, Yu M, Wang F. Emodin decreases hepatic hypoxia-inducible factor-1[Formula: see text] by inhibiting its biosynthesis. Am J Chin Med. 2016;44(5):997–1008.
Zheng CC, Hu HF, Hong P, Zhang QH, Xu WW, He QY, et al. Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer. Am J Cancer Res. 2019;9(1):186–97.
Tang Q, Zhao S, Wu J, Zheng F, Yang L, Hu J, et al. Inhibition of integrin-linked kinase expression by emodin through crosstalk of AMPKα and ERK1/2 signaling and reciprocal interplay of Sp1 and c-Jun. Cell Signal. 2015;27(7):1469–77.
Zhang H, Chen L, Bu HQ, Yu QJ, Jiang DD, Pan FP, et al. Effects of emodin on the demethylation of tumor-suppressor genes in pancreatic cancer PANC-1 cells. Oncol Rep. 2015;33(6):3015–23.
Zhou RS, Wang XW, Sun QF, Ye ZJ, Liu JW, Zhou DH, et al. Anticancer effects of emodin on HepG2 cell: evidence from bioinformatic analysis. Biomed Res Int. 2019;2019:3065818.
Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212–26.
Li N, Wang C, Zhang P, You S. Emodin inhibits pancreatic cancer EMT and invasion by upregulating microRNA1271. Mol Med Rep. 2018;18(3):3366–74.
Lin SZ, Xu JB, Ji X, Chen H, Xu HT, Hu P, et al. Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs. Mol Med Rep. 2015;12(4):5865–71.
Song K, Lv T, Chen Y, Diao Y, Yao Q, Wang Y. Emodin inhibits TGF-β2 by activating the FOXD3/miR-199a axis in ovarian cancer cells in vitro. Oncol Rep. 2018;39(5):2063–70.
Hsu HC, Liu LC, Wang HY, Hung CM, Lin YC, Ho CT, et al. Stromal fibroblasts from the interface zone of triple negative breast carcinomas induced epithelial-mesenchymal transition and its inhibition by emodin. PloS ONE. 2017;12(1):e0164661.
Song X, Zhou X, Qin Y, Yang J, Wang Y, Sun Z, et al. Emodin inhibits epithelialmesenchymal transition and metastasis of triple negative breast cancer via antagonism of CCchemokine ligand 5 secreted from adipocytes. Int J Mol Med. 2018;42(1):579–88.
Li Q, Lai Q, He C, Fang Y, Yan Q, Zhang Y, et al. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer. J Exp Clin Cancer Res. 2019;38(1):334.
Liang Z, Lu L, Mao J, Li X, Qian H, Xu W. Curcumin reversed chronic tobacco smoke exposure induced urocystic EMT and acquisition of cancer stem cells properties via Wnt/β-catenin. Cell Death Dis. 2017;8(10):e3066.
Gu J, Cui CF, Yang L, Wang L, Jiang XH. Emodin Inhibits colon cancer cell invasion and migration by suppressing epithelial-mesenchymal transition via the Wnt/beta-catenin pathway. Oncol Res. 2019;27(2):193–202.
Hu C, Dong T, Li R, Lu J, Wei X, Liu P. Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3beta/beta-catenin/ZEB1 signaling pathway. Oncol Rep. 2016;35(4):2027–34.
Lu J, Xu Y, Zhao Z, Ke X, Wei X, Kang J, et al. Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo. Onco Targets Ther. 2017;10:3579–89.
Lu J, Xu Y, Wei X, Zhao Z, Xue J, Liu P. Emodin inhibits the epithelial to mesenchymal transition of epithelial ovarian cancer cells via ILK/GSK-3beta/Slug signaling pathway. Biomed Res Int. 2016;2016:6253280.
Sun H, Li XB, Meng Y, Fan L, Li M, Fang J. TRAF6 upregulates expression of HIF-1alpha and promotes tumor angiogenesis. Can Res. 2013;73(15):4950–9.
Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie. 2005;87(3–4):361–8.
Shi GH, Zhou L. Emodin suppresses angiogenesis and metastasis in anaplastic thyroid cancer by affecting TRAF6-mediated pathways in vivo and in vitro. Mol Med Rep. 2018;18(6):5191–7.
Lin W, Zhong M, Liang S, Chen Y, Liu D, Yin Z, et al. Emodin inhibits migration and invasion of MHCC-97H human hepatocellular carcinoma cells. Exp Ther Med. 2016;12(5):3369–74.
Kim JM, Noh EM, Song HK, You YO, Jung SH, Kim JS, et al. Silencing of casein kinase 2 inhibits PKC-induced cell invasion by targeting MMP-9 in MCF-7 cells. Mol Med Rep. 2018;17(6):8397–402.
Su S, Liu Q, Chen J, Chen J, Chen F, He C, et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell. 2014;25(5):605–20.
Iwanowycz S, Wang J, Hodge J, Wang Y, Yu F, Fan D. Emodin inhibits breast cancer growth by blocking the tumor-promoting feedforward loop between cancer cells and macrophages. Mol Cancer Ther. 2016;15(8):1931–42.
Liu Q, Hodge J, Wang J, Wang Y, Wang L, Singh U, et al. Emodin reduces breast cancer lung metastasis by suppressing macrophage-induced breast cancer cell epithelial-mesenchymal transition and cancer stem cell formation. Theranostics. 2020;10(18):8365–81.
Gao J, Zheng Q, Xin N, Wang W, Zhao C. CD155, an onco-immunologic molecule in human tumors. Cancer Sci. 2017;108(10):1934–8.
Fang L, Zhao F, Iwanowycz S, Wang J, Yin S, Wang Y, et al. Anticancer activity of emodin is associated with downregulation of CD155. Int Immunopharmacol. 2019;75:105763.
Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell. 2009;16(3):183–94.
Li Z, Lin Y, Zhang S, Zhou L, Yan G, Wang Y, et al. Emodin regulates neutrophil phenotypes to prevent hypercoagulation and lung carcinogenesis. J Transl Med. 2019;17(1):90.
Keating GM. Sorafenib: a review in hepatocellular carcinoma. Target Oncol. 2017;12(2):243–53.
Kim YS, Lee YM, Oh TI, Shin DH, Kim GH, Kan SY, et al. Emodin sensitizes hepatocellular carcinoma cells to the anti-cancer effect of sorafenib through suppression of cholesterol metabolism. Int J Mol Sci. 2018;19(10):3127.
Chen S, Zhang Z, Zhang J. Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo. Drug Des Dev Ther. 2019;13:1145–53.
Phng LK, Potente M, Leslie JD, Babbage J, Nyqvist D, Lobov I, et al. Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis. Dev Cell. 2009;16(1):70–82.
Zu C, Qin G, Yang C, Liu N, He A, Zhang M, et al. Low dose emodin induces tumor senescence for boosting breast cancer chemotherapy via silencing NRARP. Biochem Biophys Res Commun. 2018;505(4):973–8.
Pan FP, Zhou HK, Bu HQ, Chen ZQ, Zhang H, Xu LP, et al. Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK. Oncol Rep. 2016;35(4):1941–9.
Thomas NA, Abraham RG, Dedi B, Krucher NA. Targeting retinoblastoma protein phosphorylation in combination with EGFR inhibition in pancreatic cancer cells. Int J Oncol. 2019;54(2):527–36.
Wang Z, Chen H, Chen J, Hong Z, Liao Y, Zhang Q, et al. Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway. Cancer Manag Res. 2019;11:8463–73.
Hintzpeter J, Seliger JM, Hofman J, Martin HJ, Wsol V, Maser E. Inhibition of human anthracycline reductases by emodin—a possible remedy for anthracycline resistance. Toxicol Appl Pharmacol. 2016;293:21–9.
Li X, Wang H, Wang J, Chen Y, Yin X, Shi G, et al. Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation. BMC Cancer. 2016;16:578.
Iyer VV, Priya PY, Kangeyavelu J. Effects of increased accumulation of doxorubicin due to emodin on efflux transporter and LRP1 expression in lung adenocarcinoma and colorectal carcinoma cells. Mol Cell Biochem. 2018;449(1–2):91–104.
Batista MN, Braga ACS, Campos GRF, Souza MM, Matos RPA, Lopes TZ, et al. Natural products isolated from oriental medicinal herbs inactivate Zika virus. Viruses. 2019;11(1):49.
Dai JP, Wang QW, Su Y, Gu LM, Zhao Y, Chen XX, et al. Emodin inhibition of influenza A virus replication and influenza viral pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB pathways. Molecules. 2017;22(10):1754.
Zhong T, Zhang LY, Wang ZY, Wang Y, Song FM, Zhang YH, et al. Rheum emodin inhibits enterovirus 71 viral replication and affects the host cell cycle environment. Acta Pharmacol Sin. 2017;38(3):392–401.
Zhang HM, Wang F, Qiu Y, Ye X, Hanson P, Shen H, et al. Emodin inhibits coxsackievirus B3 replication via multiple signalling cascades leading to suppression of translation. Biochem J. 2016;473(4):473–85.
Hall CW, Mah TF. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev. 2017;41(3):276–301.
Yang YB, Wang S, Wang C, Huang QY, Bai JW, Chen JQ, et al. Emodin affects biofilm formation and expression of virulence factors in Streptococcus suis ATCC700794. Arch Microbiol. 2015;197(10):1173–80.
Yan X, Gu S, Shi Y, Cui X, Wen S, Ge J. The effect of emodin on Staphylococcus aureus strains in planktonic form and biofilm formation in vitro. Arch Microbiol. 2017;199(9):1267–75.
Liu M, Peng W, Qin R, Yan Z, Cen Y, Zheng X, et al. The direct anti-MRSA effect of emodin via damaging cell membrane. Appl Microbiol Biotechnol. 2015;99(18):7699–709.
Ji X, Liu X, Peng Y, Zhan R, Xu H, Ge X. Comparative analysis of methicillin-sensitive and resistant Staphylococcus aureus exposed to emodin based on proteomic profiling. Biochem Biophys Res Commun. 2017;494(1–2):318–24.
Li L, Tian Y, Yu J, Song X, Jia R, Cui Q, et al. iTRAQ-based quantitative proteomic analysis reveals multiple effects of emodin to Haemophilus parasuis. J Proteomics. 2017;166:39–47.
Harikrishnan R, Jawahar S, Thamizharasan S, Paray BA, Al-Sadoon MK, Balasundaram C. Immune defense of emodin enriched diet in Clarias batrachus against Aeromonas hydrophila. Fish Shellfish Immunol. 2018;76:13–20.
Jung HA, Ali MY, Choi JS. Promising inhibitory effects of anthraquinones, naphthopyrone, and naphthalene glycosides, from Cassia obtusifolia on α-glucosidase and human protein tyrosine phosphatases 1B. Molecules. 2016;22(1):28.
Arvindekar A, More T, Payghan PV, Laddha K, Ghoshal N, Arvindekar A. Evaluation of anti-diabetic and alpha glucosidase inhibitory action of anthraquinones from Rheum emodi. Food Funct. 2015;6(8):2693–700.
Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes. 2011;60(7):1917–25.
Wang Z, Yang L, Fan H, Wu P, Zhang F, Zhang C, et al. Screening of a natural compound library identifies emodin, a natural compound from Rheum palmatum Linn that inhibits DPP4. PeerJ. 2017;5:e3283.
Yu L, Gong L, Wang C, Hu N, Tang Y, Zheng L, et al. Radix polygoni multiflori and its main component emodin attenuate non-alcoholic fatty liver disease in zebrafish by regulation of AMPK signaling pathway. Drug Des Dev Ther. 2020;14:1493–506.
Zhang X, Zhang R, Lv P, Yang J, Deng Y, Xu J, et al. Emodin up-regulates glucose metabolism, decreases lipolysis, and attenuates inflammation in vitro. J Diabetes. 2015;7(3):360–8.
Wang S, Li X, Guo H, Yuan Z, Wang T, Zhang L, et al. Emodin alleviates hepatic steatosis by inhibiting sterol regulatory element binding protein 1 activity by way of the calcium/calmodulin-dependent kinase kinase-AMP-activated protein kinase-mechanistic target of rapamycin-p70 ribosomal S6 kinase signaling pathway. Hepatol Res. 2017;47(7):683–701.
Li X, Xu Z, Wang S, Guo H, Dong S, Wang T, et al. Emodin ameliorates hepatic steatosis through endoplasmic reticulum-stress sterol regulatory element-binding protein 1c pathway in liquid fructose-feeding rats. Hepatol Res. 2016;46(3):E105-117.
Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology—divergent pathophysiology. Nat Rev Endocrinol. 2017;13(12):710–30.
Li J, Ding L, Song B, Xiao X, Qi M, Yang Q, et al. Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway. Eur J Pharmacol. 2016;770:99–109.
Xiao D, Hu Y, Fu Y, Wang R, Zhang H, Li M, et al. Emodin improves glucose metabolism by targeting microRNA-20b in insulin-resistant skeletal muscle. Phytomedicine. 2019;59:152758.
Cao Y, Chang S, Dong J, Zhu S, Zheng X, Li J, et al. Emodin ameliorates high-fat-diet induced insulin resistance in rats by reducing lipid accumulation in skeletal muscle. Eur J Pharmacol. 2016;780:194–201.
Cheng L, Zhang S, Shang F, Ning Y, Huang Z, He R, et al. Emodin improves glucose and lipid metabolism disorders in obese mice via activating brown adipose tissue and inducing browning of white adipose tissue. Front Endocrinol. 2021;12:618037.
Abu Eid S, Adams M, Scherer T, Torres-Gómez H, Hackl MT, Kaplanian M, et al. Emodin, a compound with putative antidiabetic potential, deteriorates glucose tolerance in rodents. Eur J Pharmacol. 2017;798:77–84.
Quattrini L, La Motta C. Aldose reductase inhibitors: 2013-present. Expert Opin Ther Pat. 2019;29(3):199–213.
Tian N, Gao Y, Wang X, Wu X, Zou D, Zhu Z, et al. Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy. Drug Des Dev Ther. 2018;12:2195–211.
Jing D, Bai H, Yin S. Renoprotective effects of emodin against diabetic nephropathy in rat models are mediated via PI3K/Akt/GSK-3β and Bax/caspase-3 signaling pathways. Exp Ther Med. 2017;14(5):5163–9.
Xu S, Lv Y, Zhao J, Wang J, Zhao X, Wang S. Inhibitory effects of Shenkang injection and its main component emodin on the proliferation of high glucose-induced renal mesangial cells through cell cycle regulation and induction of apoptosis. Mol Med Rep. 2016;14(4):3381–8.
Schalkwijk CG, Stehouwer CDA. Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases. Physiol Rev. 2020;100(1):407–61.
Sohn E, Kim J, Kim CS, Jo K, Kim JS. Extract of Rhizoma Polygonum cuspidatum reduces early renal podocyte injury in streptozotocin-induced diabetic rats and its active compound emodin inhibits methylglyoxal-mediated glycation of proteins. Mol Med Rep. 2015;12(4):5837–45.
Fan L, Zhang H, Li X, Yang G, Ru J, Liu T. Emodin protects hyperglycemia-induced injury in PC-12 cells by up-regulation of miR-9. Mol Cell Endocrinol. 2018;474:194–200.
Zhang Y, Yang X, Jia Z, Liu J, Yan X, Dai Y, et al. Proteomics unravels emodin causes liver oxidative damage elicited by mitochondrial dysfunction. Front Pharmacol. 2020;11:416.
Chen C, Gao J, Wang TS, Guo C, Yan YJ, Mao CY, et al. NMR-based metabolomic techniques identify the toxicity of emodin in HepG2 cells. Sci Rep. 2018;8(1):9379.
Luo T, Li N, He YQ, Weng SQ, Wang T, Zou QX, et al. Emodin inhibits human sperm functions by reducing sperm [Ca(2+)]i and tyrosine phosphorylation. Reprod Toxicol. 2015;51:14–21.
Teng Z, Yuan C, Zhang F, Huan M, Cao W, Li K, et al. Intestinal absorption and first-pass metabolism of polyphenol compounds in rat and their transport dynamics in Caco-2 cells. PloS ONE. 2012;7(1):e29647.
Qin B, Xu Y, Chen J, Huang W, Peng Y, Zheng J. Chemical reactivity of emodin and its oxidative metabolites to thiols. Chem Res Toxicol. 2016;29(12):2114–24.
Xu Y, Wang Q, Yin Z, Gao X. On-line incubation and real-time detection by ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry for rapidly analyzing metabolites of anthraquinones in rat liver microsomes. J Chromatogr A. 2018;1571:94–106.
Huang Z, Xu Y, Wang Q, Gao X. Metabolism and mutual biotransformations of anthraquinones and anthrones in rhubarb by human intestinal flora using UPLC-Q-TOF/MS. J Chromatogr B. 2019;1104:59–66.
Park B, Yoon W, Yun J, Ban E, Yun H, Kim A. Emodin-nicotinamide (1:2) cocrystal identified by thermal screening to improve emodin solubility. Int J Pharm. 2019;557:26–35.
Liu W, Tang L, Ye L, Cai Z, Xia B, Zhang J, et al. Species and gender differences affect the metabolism of emodin via glucuronidation. AAPS J. 2010;12(3):424–36.
Ban E, Park M, Jeong S, Kwon T, Kim EH, Jung K, et al. Poloxamer-based thermoreversible gel for topical delivery of emodin: influence of P407 and P188 on solubility of emodin and its application in cellular activity screening. Molecules. 2017;22(2):246.
Campos PP, Fraceto LF, Ferreira M. Layer-by-layer films containing emodin or emodin encapsulated in liposomes for transdermal applications. Colloids Surf B. 2018;162:69–75.
Wei W, Meng C, Wang Y, Huang Y, Du W, Li H, et al. The interaction between self—assembling peptides and emodin and the controlled release of emodin from in-situ hydrogel. Artif Cells Nanomed Biotechnol. 2019;47(1):3961–75.
Huang J, Gong W, Chen Z, Huang J, Chen Q, Huang H, et al. Emodin self-emulsifying platform ameliorates the expression of FN, ICAM-1 and TGF-β1 in AGEs-induced glomerular mesangial cells by promoting absorption. Eur J Pharm Sci. 2017;99:128–36.
Liu W, Feng Q, Li Y, Ye L, Hu M, Liu Z. Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin. Toxicol Appl Pharmacol. 2012;265(3):316–24.
Wu W, Hu N, Zhang Q, Li Y, Li P, Yan R, et al. In vitro glucuronidation of five rhubarb anthraquinones by intestinal and liver microsomes from humans and rats. Chem Biol Interact. 2014;219:18–27.
Zhang T, Dong D, Lu D, Wang S, Wu B. Cremophor EL-based nanoemulsion enhances transcellular permeation of emodin through glucuronidation reduction in UGT1A1-overexpressing MDCKII cells. Int J Pharm. 2016;501(1–2):190–8.
Akkol EK, Tatlı II, Karatoprak G, Ağar OT, Yücel Ç, Sobarzo-Sánchez E, et al. Is emodin with anticancer effects completely innocent? Two sides of the coin. Cancers. 2021;13(11):2733.
Yang K, Jin MJ, Quan ZS, Piao HR. Design and synthesis of novel anti-proliferative emodin derivatives and studies on their cell cycle arrest, apoptosis pathway and migration. Molecules. 2019;24(5):884.
Khan H, Jia W, Yu Z, Zaib T, Feng J, Jiang Y, et al. Emodin succinyl ester inhibits malignant proliferation and migration of hepatocellular carcinoma by suppressing the interaction of AR and EZH2. Biomed Pharmacother. 2020;128:110244.
Koerner SK, Hanai JI, Bai S, Jernigan FE, Oki M, Komaba C, et al. Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase. Eur J Med Chem. 2017;126:920–8.
Chen Y, Zheng J, Gan D, Chen Y, Zhang N, Chen Y, et al. E35 ablates acute leukemia stem and progenitor cells in vitro and in vivo. J Cell Physiol. 2020;235(11):8023–34.
Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci. 2009;30(11):592–9.
Liu H, Gao M, Xu H, Guan X, Lv L, Deng S, et al. A Promising emodin-loaded poly (lactic-co-glycolic Acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy. Pharm Res. 2016;33(1):217–36.
Dong H, Wu G, Xu H, Zhang C, Wang J, Gao M, et al. N-acetylaminogalactosyl-decorated biodegradable PLGA-TPGS copolymer nanoparticles containing emodin for the active targeting therapy of liver cancer. Artif Cells Nanomed Biotechnol. 2018;46(sup2):260–72.
Wang D, Sun M, Zhang Y, Chen Z, Zang S, Li G, et al. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis. Phytomedicine. 2020;78:153293.
Ding W, Sun J, Lian H, Xu C, Liu X, Zheng S, et al. The Influence of shuttle-shape emodin nanoparticles on the Streptococcus suis Biofilm. Front Pharmacol. 2018;9:227.
Ye P, Wei S, Luo C, Wang Q, Li A, Wei F. Long-term Effect against methicillin-resistant Staphylococcus aureus of emodin released from coaxial electrospinning nanofiber membranes with a biphasic profile. Biomolecules. 2020;10(3):362.
Li H, Yang T, Zhou H, Du J, Zhu B, Sun Z. Emodin combined with nanosilver inhibited sepsis by anti-inflammatory protection. Front Pharmacol. 2016;7:536.
Fu M, Tang W, Liu JJ, Gong XQ, Kong L, Yao XM, et al. Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer. J Drug Target. 2020;28(3):245–58.
Liu H, Zhuang Y, Wang P, Zou T, Lan M, Li L, et al. Polymeric lipid hybrid nanoparticles as a delivery system enhance the antitumor effect of emodin in vitro and in vivo. J Pharm Sci. 2021;110(8):2986–96.
Song Y, Sheng Z, Xu Y, Dong L, Xu W, Li F, et al. Magnetic liposomal emodin composite with enhanced killing efficiency against breast cancer. Biomater Sci. 2019;7(3):867–75.
Wu W, Yan R, Yao M, Zhan Y, Wang Y. Pharmacokinetics of anthraquinones in rat plasma after oral administration of a rhubarb extract. Biomed Chromatogr. 2014;28(4):564–72.
Liu W, Zheng Z, Liu X, Gao S, Ye L, Yang Z, et al. Sensitive and robust UPLC-MS/MS method to determine the gender-dependent pharmacokinetics in rats of emodin and its glucuronide. J Pharm Biomed Anal. 2011;54(5):1157–62.
Yu F, Yu N, Peng J, Zhao Y, Zhang L, Wang X, et al. Emodin inhibits lipid accumulation and inflammation in adipose tissue of high-fat diet-fed mice by inducing M2 polarization of adipose tissue macrophages. FASEB J. 2021;35(7):e21730.
Kon R, Ikarashi N, Nagoya C, Takayama T, Kusunoki Y, Ishii M, et al. Rheinanthrone, a metabolite of sennoside A, triggers macrophage activation to decrease aquaporin-3 expression in the colon, causing the laxative effect of rhubarb extract. J Ethnopharmacol. 2014;152(1):190–200.
Zeng YQ, Dai Z, Lu F, Lu Z, Liu X, Chen C, et al. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease. Oncotarget. 2016;7(14):17468–78.
Liu B, Piao X, Niu W, Zhang Q, Ma C, Wu T, et al. Kuijieyuan decoction improved intestinal barrier injury of ulcerative colitis by affecting TLR4-dependent PI3K/AKT/NF-κB oxidative and inflammatory signaling and gut microbiota. Front Pharmacol. 2020;11:1036.
Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021;371(6529):602–9.